logo

Ligand Pharmaceuticals Inc (LGND)



Trade LGND now with
  Date
  Headline
2/21/2018 4:03:17 PM Ligand Pharma Q4 Loss/share $0.33 Vs. Loss $0.15 Year Ago
1/22/2018 9:01:49 AM Ligand Enters Into Worldwide OmniAb Platform License Agreement With Ferring Pharma
1/11/2018 9:02:50 AM Ligand Enters Worldwide OmniAb Platform License Agreement With Glenmark Pharmaceuticals
1/3/2018 9:05:49 AM Ligand Says Now Expects FY17 Total Revenue Of About $140 Mln, Adj. EPS Of $3.13-$3.16
11/9/2017 4:04:19 PM Ligand Pharmaceuticals Q3 EPS $0.36 Vs. $0.05 Year Ago
10/4/2017 4:11:07 PM Ligand To Acquire Crystal Bioscience
9/5/2017 8:03:10 AM Ligand Announces Top-Line Results From Phase 2 Study Of LGD-6972 In Patients With Type 2 Diabetes
8/21/2017 9:01:45 AM Ligand Appoints Nancy Gray To Board
8/18/2017 9:01:11 AM Ligand To Receive $2 Mln From WuXi Biologics For Licensing Clinical-Stage Anti-PD-1 Antibody
8/7/2017 4:03:13 PM Ligand Pharmaceuticals Q2 EPS $0.26 Vs. Loss $0.30 Year Ago